Singular Medical

Singular Medical, established in 2017, is a high-tech enterprise focused on the research, production, and sales of a series of cardiac rhythm management products, including Implantable Cardioverter Defibrillators (ICD), Implantable Cardiac Monitors (ICM), and Implantable Pacemakers. The company's headquarters is located in the Suzhou High-Tech Zone Medical Device Park, with a 2800-square-meter manufacturing plant, and it has research and development centers in Beijing and Irvine, USA.Singular Medical has gathered various professionals in the fields of circuits, chips, software, structural processes, and clinical medicine, possessing a highly skilled professional team in product development, quality control, regulatory submissions, and enterprise management. With rich technical reserves and a specialized talent pool, Singular Medical is committed to providing a full set of solutions for patients with arrhythmia, from monitoring, diagnosis, and treatment to postoperative follow-up.Singular Medical has received investments from Northern Light Venture Capital, Yuan Yi Capital, Zhen Fund, CAS Star, and SND Ventures.